Significance of the invasive strategy after acute myocardial infarction on prognosis and secondary preventive medication: a nationwide study of 6364 women and 11,915 men.

Authors:
  • SGSøren Galatius
    Søren Galatius
  • MMMette Madsen
    Mette Madsen
  • RSRikke Sørensen
    Rikke Sørensen
  • JMJan Kyst Madsen
    Jan Kyst Madsen
  • AIAllan Zeeberg Iversen
    Allan Zeeberg Iversen
  • HTHans-Henrik Tilsted
    Hans-Henrik Tilsted
  • SHSteffen Helqvist
    Steffen Helqvist
  • PMPoul Erik Mortensen
    Poul Erik Mortensen
  • PNPer Hostrup Nielsen
    Per Hostrup Nielsen
  • SASteen Zabell Abildstrøm
    Steen Zabell Abildstrøm

  • 1 January 2012
    • journal article
    • research article
Abstract
To describe gender-specific long-term outcome and initiation of secondary preventive medication among patients with acute myocardial infarction (AMI). Observational cohort study. Nationwide registries. We included 18,279 patients: 6364 women (35%) and 11,915 men (65%), admitted with AMI (median age, 67 years; range, 30-90 years) surviving for at least 2 months. According to sex, patients were stratified by invasive treatment strategy: (1) revascularized; (2) examined with coronary angiography (CAG) but not revascularized; and (3) not examined with CAG. All-cause mortality and readmission with AMI. Initiation of secondary preventive medication. Of 18,279 patients with a first AMI who survived 2 months, 1857 women (29%) and 1756 men (15%) were not examined with CAG (P<.001), 1295 women (20%) and 1563 men (13%) were examined but not revascularized (P<.001), and 3212 women (51%) and 8596 men (72%) were revascularized (P<.001). Not being examined with CAG after AMI was associated with a three-fold increase in risk of death and, importantly, a 50% increase in the risk of a recurrent AMI compared with patients who were revascularized. Among patients who were revascularized, 85-92% initiated recommended secondary preventive medication compared to 46-71% in patients not examined with CAG (P<.001). Initiation of secondary preventive medication was higher in men (81-84%) than in women (73-79%; P<.001), which could be ascribed to the differences in invasive strategy. In both sexes, those who were not examined had a highly increased risk of both recurrent AMI and death. Moreover, initiation of secondary preventive medication was closely related to the choice of invasive strategy disfavoring the women.